ArticleMaterials today. Bio2026

Dual-responsive peptide nanoplatform for improved lung cancer therapy via the synergistic suppression of autophagy and drug efflux.

Ziru Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.